biolimus
- Access DeniedEverolimus-Eluting Versus Biolimus-Eluting Stents With Biodegradable Polymers in Unselected Patients Undergoing Percutaneous Coronary InterventionA Randomized Noninferiority Trial With 1-Year Follow-Up (SORT OUT VIII Trial)Michael Maeng, Johnny Kahlert, et al.JACC: Cardiovascular Interventions
- Access DeniedComparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease3-Year Clinical Outcomes in the Randomized SORT OUT VI TrialBent Raungaard, Lisette Okkels Jensen, et al.JACC: Cardiovascular Interventions
- Access DeniedPolymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions4- and 12-Month Angiographic Follow-Up and Final 5-Year Clinical Outcomes of the Prospective, Multicenter BioFreedom FIM Clinical TrialRicardo A. Costa, Eberhard Grube, et al.JACC: Cardiovascular Interventions
Advertisement